Knoll Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-210,789
| Closed | -$2.6M | – | 43 |
|
|
2022
Q1 | $2.6M | Buy |
+210,789
| New | +$2.6M | 1.63% | 7 |
|
|
2021
Q1 | – | Sell |
-670,789
| Closed | -$3.62M | – | 40 |
|
|
2020
Q4 | $3.62M | Buy |
670,789
+50,000
| +8% | +$270K | 2.47% | 8 |
|
|
2020
Q3 | $2.83M | Sell |
620,789
-103,416
| -14% | -$471K | 2.32% | 8 |
|
|
2020
Q2 | $3.62M | Hold |
724,205
| – | – | 2.09% | 7 |
|
|
2020
Q1 | $2.28M | Hold |
724,205
| – | – | 2.14% | 8 |
|
|
2019
Q4 | $1.88M | Hold |
724,205
| – | – | 1.39% | 12 |
|
|
2019
Q3 | $2.29M | Hold |
724,205
| – | – | 2.09% | 12 |
|
|
2019
Q2 | $2.44M | Hold |
724,205
| – | – | 2% | 11 |
|
|
2019
Q1 | $2.21M | Hold |
724,205
| – | – | 1.68% | 11 |
|
|
2018
Q4 | $1.13M | Hold |
724,205
| – | – | 1.29% | 9 |
|
|
2018
Q3 | $1.87M | Hold |
724,205
| – | – | 1.58% | 9 |
|
|
2018
Q2 | $1.9M | Hold |
724,205
| – | – | 1.61% | 10 |
|
|
2018
Q1 | $2M | Hold |
724,205
| – | – | 2.05% | 7 |
|
|
2017
Q4 | $2.33M | Hold |
724,205
| – | – | 2.06% | 7 |
|
|
2017
Q3 | $3M | Hold |
724,205
| – | – | 2.56% | 5 |
|
|
2017
Q2 | $3.85M | Hold |
724,205
| – | – | 5.11% | 4 |
|
|
2017
Q1 | $4.16M | Hold |
724,205
| – | – | 6.27% | 4 |
|
|
2016
Q4 | $2.87M | Buy |
+724,205
| New | +$2.87M | 5.03% | 4 |
|